ENP Newswire -
Release date- 11092013 - Researchers at the
Results of the study were published in Nanomedicine: Nanotechnology, Biology and Medicine.
Nanotechnology has been used to create targeted therapy for several different types of cancer. For example, nanodiamonds have been used to treat breast and liver cancer. However, few research initiatives have targeted glioblastoma, an aggressive brain cancer.
Nanodiamonds are small particles of carbon atoms. Arranged like an angular soccer ball, nanodiamond surfaces are hydrophilic. This allows them to attract water and other molecules, such as drugs. By binding anticancer drugs to diamonds, researchers are able to improve agent uptake in cancerous tumors. While tumors may normally reject chemotherapeutics, a chemotherapeutic agent attached to a nanoparticle is readily absorbed by many tumors.
In the latest study, researcher bound doxorubicin, a chemotherapy agent, to nanodiamonds. These were then delivered directly to a tumor through injection. Since nanodiamonds bind to the chemotherapy agent until it reaches the tumor, this type of nanotechnology can protect healthy cells in the body and minimize the risk of side effects.
When nanodiamonds reach a tumor, the unique physiological properties of cancer cells promote the release of doxorubicin. With this delivery method, doxorubicin remains in a tumor for a longer period of time, decreasing the viability of cancerous cells. In addition, nanodiamonds can limit the spread of doxorubicin to surrounding, healthy cells.
'Nanomaterials are promising vehicles for treating different types of cancer,' noted
[Editorial queries for this story should be sent to firstname.lastname@example.org]
((Comments on this story may be sent to email@example.com))
Most Popular Stories
- American Airlines, US Airways Complete Merger
- Dell Offers Undisclosed Number of Employee Buyouts
- ACA Delay Stresses Small Businesses
- Saab Gets Back into the Game; U.S. Auto Sales Soar
- General Dynamics Plans 200 New Jobs in N.M.
- Unemployed Wait as Lawmakers Debate
- Authorities Close to Deal with JPMorgan Chase over Madoff Response
- Questions Remain in Jenni Rivera's Death
- U.S. Stocks Rise on Sysco Acquisition
- Tech Giants Call for Controls on Government Snooping